Rachel Miller
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rachel Miller sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,751 sponsors by registered trial count).
Rachel Miller: 6 sponsored US clinical trials, 2 recruiting.
Rachel Miller sponsors 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Endometrial Cancer, with 1 trials.
Upper-quartile sponsor footprint
Rachel Miller sits in the upper quartile of the sponsor corpus (#2,085 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
NCT06677112
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
NCT03089554
PITCH - Impacting Hereditary Cancer Testing
NCT07090109
Chemotherapy-Induced Cognitive Impairment in Ovarian Cancer Patients
NCT03324945
Biobehavioral Intervention in Gynecologic Oncology Patients
NCT02454036
Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma
NCT01519869
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
Therapeutic Areas
What is open in the Rachel Miller pipeline
2 recruiting of 6 indexed (33% open); 3 completed (50%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Endometrial Cancer (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.